It’s the first pill that lowers blood cholesterol far better than statins, medicines that a quarter of adults take to reduce ...

Personalis stock reversed lower Friday on a rumor Merck and at least two other suitors are trying to buy the small genomics ...

Merck (MRK) stock gains after FDA approves Lipfendra, the first oral PCSK9 inhibitor for high cholesterol, priced ...

While Wall Street fretted over the future of its biggest blockbuster, a pair of new drugs were already showing the company's next act was well underway.

Wondering whether Merck at US$128.66 is still offering fair value, or if the recent run means you are paying too much for the stock? The share price moves have been strong, with Merck showing returns ...

Shares of Merck & Co. Inc. MRK rallied 1.64% to $128.86 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.45% to 7,503.85 and ...

Merck MRK is set to report its fourth-quarter and full-year 2025 earnings on Feb. 3, before market open. The Zacks Consensus Estimate for fourth-quarter sales and earnings is pegged at $16.19 billion ...

Shares of Merck & Co. Inc. MRK shed 2.15% to $126.78 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.72% to 7,537.43 and the ...

Merck is one of the world's largest drug companies. Although it isn't a player in the GLP-1 space, it has a well-supported dividend and a proven track record of dividend growth. 10 stocks we like ...